Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers
- 1 August 1984
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 3 (4), 355-359
- https://doi.org/10.1007/bf01977494
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivativesAntimicrobial Agents and Chemotherapy, 1984
- In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agentAntimicrobial Agents and Chemotherapy, 1984
- Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984
- Activity of ciprofloxacin (BAYo 9867) against pseudomonas aeruginosa and ampicillin-resistant EnterobacteriaceaeInfection, 1983
- In vitro activity of ciprofloxacin (Bay o 9867)Antimicrobial Agents and Chemotherapy, 1983
- In vitro activity of ciprofloxacin, norfloxacin and nalidixic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- Norfloxacin disposition after sequentially increasing oral dosesAntimicrobial Agents and Chemotherapy, 1983
- Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humansAntimicrobial Agents and Chemotherapy, 1983
- Noncompartmental Determination of the Steady‐State Volume of DistributionJournal of Pharmaceutical Sciences, 1979